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Abstract We have generated a mouse model for hepatic
ischemia in which surgical subcutaneous transposition of the
spleen allows hepatic ischemia to be applied without affecting
other tissues. Using this mouse model we investigated the
relationship between the length of ischemic periods in the liver
and subsequent liver function; furthermore, we assayed the
activation of c-Jun N-terminal kinase (JNK) during ischemia and
reperfusion. Although prior to this study only the activated form
of JNK was known to be translocated to the nucleus, we found
that JNK translocates to the nucleus during ischemia without
activation and is then activated during reperfusion. These results
suggest a novel mechanism of JNK activation.
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1. Introduction
Prolonged ischemia leads to cell death and irreversible or-
gan dysfunction, while the e¡ects of transient ischemia can be
reversed by reperfusion. The length of ischemic periods is,
therefore, the key to limiting damage to the a¡ected tissue.
In response to the reperfusion of ischemic tissue, immediate
early genes (e.g. c-jun, c-fos, Egr-1) are induced [1]. These gene
products are involved in a variety of di¡erent cell fate-related
processes, such as apoptosis [2,3], proliferation [4], and di¡er-
entiation [5,6]. The transactivation activity of the c-Jun tran-
scription factor is regulated by phosphorylation at Ser63 and
Ser73 within the amino-terminal activation domain [7,8]. c-Jun
N-terminal kinase (JNK; also known as stress-activated pro-
tein kinase, SAPK), a member of the mitogen-activated pro-
tein kinase (MAPK) family, binds to the c-Jun activation
domain and phosphorylates it on Ser63 and Ser73 [9,10]. Tran-
scription of c-fos is induced by phosphorylation of the tran-
scription factor TCF (ternary complex factor), which binds to
the serum responsible element in the c-fos promoter [11]. The
phosphorylation of TCF is mediated not only by JNK [12],
but also by ERK [13], another member of the MAPK family.
MAPKs are activated in response to various extracellular
stimuli, including growth factors and environmental stresses
[14,15]. In the cytoplasm, MAPKs are activated and subse-
quently translocated to the nucleus [12,16,17], where the acti-
vated MAPKs phosphorylate their substrates, including c-Jun
and TCF. Thus, nuclear translocation of MAPKs is a crucial
step in signal transduction. Recently JNK was shown to be
activated during ischemia and reperfusion in the heart [18]
and kidney [19]; however, the mechanism of JNK activation
remains unclear.
In the present study we surgically generated a model mouse
that allows us to perform hepatic ischemia without a¡ecting
other tissues. Using this mouse we investigated the relation-
ship between the length of ischemic periods in liver and its
subsequent function. In addition, we examined how ischemia
and reperfusion in the liver a¡ect the subcellular localization
of JNK and the time course of its activation.
2. Materials and methods
2.1. Model mouse for ischemia-reperfusion
All animal experiments were conducted in accordance with local
institutional guidelines for the care and use of laboratory animals.
Slc:ddY mice (30^35 g) were fed a standard laboratory diet and water
ad libitum before surgery. To prevent mesenteric venous hypertension
during hepatic ischemia, subcutaneous transposition of the spleen was
performed essentially as described by Bengmark et al. [20], who had
applied this surgical treatment to the rat. Total hepatic ischemia of the
model mouse was induced by occlusion of the hepatic artery and
portal vein with a small vascular clip. Reperfusion was initiated by
removing the clip.
2.2. Evaluation of liver function
Blood samples were obtained after 1 h of reperfusion of ischemic
livers, and subjected to Normotest [21] to measure the coagulation
activity of blood coagulation factors II, VII, and X, whose levels
re£ect liver function.
2.3. TUNEL method
Specimens were prepared as described previously [22], and apop-
totic cells were detected by the TUNEL method [23] using ApopTag
Plus (Oncor).
2.4. Protein kinase assay
Liver samples were homogenized in bu¡er (50 mM HEPES, 100
mM NaCl, 2 mM EDTA, 1% NP-40, 1 mM phenylmethylsulfonyl
£uoride, 20 mM L-glycerophosphate, and 20 mM p-nitrophenyl phos-
phate), and immunoprecipitated with anti-JNK antibody G151-333.8
(Pharmingen) or anti-ERK antibody sc-154 (Santa Cruz). Immuno-
complex kinase assays were carried out at 30‡C for 20 min using 2 Wg
of substrate, 20 WM ATP and 5 WCi of [Q-32P]ATP in 30 Wl of bu¡er
(25 mM HEPES pH 7.6, 20 mM MgCl2, 20 mM L-glycerophosphate,
20 mM p-nitrophenyl phosphate, and 2 mM dithiothreitol). Gluta-
thione S-transferase (GST)-c-Jun and myelin basic protein (MBP)
were used as substrates in the JNK and ERK kinase assays, respec-
tively.
2.5. Immunohistochemistry
Specimens were prepared and immunohistochemical staining of
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JNK was carried out with anti-JNK antibody sc-474-G (Santa Cruz)
as described previously [22].
3. Results and discussion
To examine the relationship between the length of ischemic
periods in liver and the function of the liver, we generated a
model mouse by subcutaneous transposition of the spleen. By
3 weeks after surgery, the mice had developed portasystemic
shunts that enabled hepatic ischemia to be applied without
a¡ecting other tissues. Liver function was evaluated by meas-
uring the activities of blood coagulation factors II, VII, and
X. The mouse was subjected to hepatic ischemia for 10, 15, or
30 min, and the coagulation activities were measured after 1 h
of reperfusion. As shown in Fig. 1, ischemia for 10 min had
little e¡ect on function, whereas ischemia for 15 and 30 min
signi¢cantly reduced liver function, to 53 and 58%, respec-
tively, of the function in a control mouse.
We next examined the appearance of apoptotic cells during
ischemia (0^15 min) and reperfusion (0^48 h) in the liver.
Apoptosis was detected by in situ staining of cells using the
TUNEL method. In response to reperfusion after 10 min of
ischemia, apoptotic cells appeared around the portal and hep-
atic veins (Fig. 2A), their number peaked after 6 h of reper-
fusion (Fig. 2B). By contrast, ischemia for 15 min caused no
or a very small number of apoptotic cells during reperfusion
(Fig. 2B). Necrotic cells were detected in livers subjected to
ischemia for 30 min, but not for shorter periods (10 or 15
min) (data not shown). Taking into account the e¡ect of the
length of ischemic periods on the liver function (Fig. 1), these
results may suggest that apoptosis plays a protective role in
tissue subjected to ischemia and reperfusion.
JNK activity during reperfusion (0^30 min) after hepatic
ischemia for 10 or 15 min was investigated using GST-c-Jun
as the substrate (Fig. 3). JNK was not activated by 10 min of
ischemia alone; however, reperfusion of the ischemic liver
increased JNK activity with a peak at 20 min (4.7-fold in-
crease over control). The activity almost completely disap-
peared after 30 min of reperfusion. No or very little activation
of JNK was observed during reperfusion after 15 min of is-
chemia. Recently, Bendinelli et al. [24] reported JNK activa-
tion during reperfusion for 30 min to 1 h after partial hepatic
ischemia. The di¡erence in time course from our result is most
likely due to the di¡erent degrees of hepatic ischemia. Our
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Fig. 2. Apoptosis induced by ischemia and reperfusion. A: Livers were subjected to ischemia for 0 min (left panel) or reperfusion for 1 h after
10 min ischemia (right panel). Specimens were prepared and apoptotic cells were detected by the TUNEL method as described in Section 2.
The right panel shows TUNEL-positive nuclei around the hepatic vein. Scale bar is 50 Wm. B: After 10 or 15 min of hepatic ischemia, reperfu-
sion was carried out for the indicated periods of time. 30^50 high-power ¢elds (HPF; 200^300 hepatocytes per ¢eld) were scored for TUNEL-
positive nuclei. Bars represent mean þ S.E.M. (n = 5). Asterisks indicate a signi¢cant di¡erence from control (10 min ischemia alone; P6 0.05).
Fig. 3. Activation of JNK and ERK during ischemia and reperfu-
sion. Livers were subjected to ischemia and reperfusion for the indi-
cated periods of time. Homogenates of the liver samples were pre-
pared, and immunocomplex kinase assays were carried out as
described in Section 2. GST-c-Jun and MBP were used as substrates
for the JNK and ERK kinase assays, respectively. The level of acti-
vation relative to the control (no ischemia) is indicated. Experiments
were repeated at least twice with similar results.
Fig. 1. E¡ect of the length of ischemic periods on liver function.
Livers were subjected to ischemia for the indicated periods of time.
Blood samples were obtained after 1 h of reperfusion, and used to
measure coagulation activity to evaluate liver function. Bars repre-
sent mean þ S.E.M. (n = 4). Asterisks indicate a signi¢cant di¡erence
from control (no ischemia; P6 0.05).
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mouse model permits complete hepatic ischemia; reperfusion
following the higher degree of hepatic ischemia could cause
the quicker JNK response.
We also examined whether the JNK-related kinase, ERK,
would respond to ischemia and reperfusion in the same man-
ner as JNK. ERK was moderately activated during postische-
mic reperfusion after ischemia was maintained for 10 or 15
min (Fig. 3). These results indicate that the mechanism of
JNK activation during postischemic reperfusion is di¡erent
from that of ERK activation, as suggested by Knight and
Buxton [18].
An immunohistochemical study using anti-JNK antibody
was carried out to examine the subcellular localization of
JNK during ischemia and reperfusion in the liver (Fig. 4).
Unexpectedly, ischemia alone for 10 min induced the trans-
location of JNK to the nucleus (Fig. 4B), even though we
observed no activation of JNK at that time (see Fig. 3).
JNK remained in the nucleus during postischemic reperfusion
for at least 20 min (Fig. 4C). Taken together with the time
course of JNK activation shown in Fig. 3, these results sug-
gest that JNK translocates to the nucleus during ischemia
without activation and is subsequently activated during reper-
fusion. Because MAPKs, including JNK, are known to be
primarily activated in the cytoplasm in response to stimuli
and then translocated to the nucleus, our data suggest a novel
mechanism of JNK activation. During the course of our
study, Mizukami et al. [25] reported similar results using per-
fused rat heart. This novel scheme for JNK activation, there-
fore, seems not to be restricted to the liver, but common to a
number of tissues.
JNK can be activated by a dual-speci¢city threonine/tyro-
sine kinase SEK1 (also known as MKK4/JNKK) [26^28].
However, stimuli such as UV light activate JNK in a SEK1-
independent manner [29]. At present we do not know what
signaling molecules are involved in JNK activation during
postischemic reperfusion. The technique described here can
be applied to transgenic mice expressing altered signaling mol-
ecules, such as a dominant inhibitory mutant of SEK1. Use of
these model mice should provide important clues to under-
standing the signaling pathway leading to JNK activation
during ischemia and reperfusion.
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